Literature DB >> 31928890

Peripheral intravenous catheter needleless connector decontamination study-Randomized controlled trial.

Karen Slater1, Marie Cooke2, Fiona Fullerton3, Michael Whitby4, Jennine Hay5, Scott Lingard5, Joel Douglas5, Claire M Rickard2.   

Abstract

BACKGROUND: Needleless connectors (NCs) were introduced to reduce health care work needlestick injuries (NSIs). If not decontaminated prior to use, NCs can be a portal for patient blood stream infections. The optimal disinfectant, and its application duration, for NC decontamination has not been empirically established.
METHODS: Factorial design randomized controlled trial comparing 70% isopropyl alcohol (IPA) and 2% chlorhexidine gluconate (CHG) in 70% IPA for 5, 10, or 15 seconds, in adult medical patients with peripheral intravenous catheters.
RESULTS: At baseline, 153 of 300 NCs (51%) grew microorganisms commonly found on the skin. Decontamination was successful in 150/153 (98%). There was no significant difference in decontamination between 70% IPA or 2% CHG in 70% IPA (P = .62), or decontamination for 5, 10, or 15 seconds (P = .21).
CONCLUSIONS: There was no difference in the effectiveness of 70% IPA and 2% CHG in 70% IPA for NC decontamination for peripheral intravenous catheters in the clinical environment. Successful decontamination was not different for applications of 5, 10, and 15 seconds; 15 seconds did not always remove all microorganisms. Factors such as cost, feasibility of compliance, and low risk of allergy support 5 seconds decontamination with 70% IPA as an acceptable approach. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood stream infection; Microbiology

Mesh:

Substances:

Year:  2020        PMID: 31928890     DOI: 10.1016/j.ajic.2019.11.030

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  1 in total

1.  Microbiological colonization of peripheral venous catheters: a prospective observational study in a Swedish county hospital.

Authors:  D Juhlin; F Hammarskjöld; S Mernelius; K Taxbro; S Berg
Journal:  Infect Prev Pract       Date:  2021-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.